Back to search

Article

METTL13 Inhibits Progression of Clear Cell Renal Cell Carcinoma with Repression on PI3K/AKT/mTOR/HIF-1α Pathway and c-Myc Expression

2021-02-19

Abstract excerpt

<title>Abstract</title> <p>Background: Clear cell renal cell carcinoma (ccRCC) is the most common and aggressive type of renal malignancy. Methyltransferase like 13 (METTL13) functions as an oncogene in most of human cancers, but its function and mechanism in ccRCC remain unreported. <h4>Methods:</h4> qRT-PCR, western blot and immunohistochemistry were used to detect METTL13’s expressions in tissues. The effects...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7fa4609a-cf47-503f-ab83-f7ae01abb906
DOI
10.21203/rs.3.rs-214061/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
METTL13 Inhibits Progression of Clear Cell Renal Cell Carcinoma with Repression on PI3K/AKT/mTOR/HIF-1α Pathway and c-Myc ExpressionDOI 10.21203/rs.3.rs-214061/v1
Select a neighboring publication to make it the new centre.